0001425289 --12-31 BTLN 300782905 Smaller Reporting Company Yes false 2019 Q1 0001425289 2019-01-01 2019-03-31 0001425289 2019-03-31 0001425289 2019-05-15 0001425289 2019-03-31 2019-03-31 0001425289 2018-12-31 0001425289 2019-01-01 2019-12-31 0001425289 2018-01-01 2018-03-31 0001425289 us-gaap:CommonStockMember 2019-01-01 2019-03-31 0001425289 us-gaap:SeriesAPreferredStockMember 2019-01-01 2019-03-31 0001425289 us-gaap:SeriesBPreferredStockMember 2019-01-01 2019-03-31 0001425289 us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember 2019-01-01 2019-03-31 0001425289 us-gaap:RetainedEarningsMember 2019-01-01 2019-03-31 0001425289 us-gaap:TreasuryStockCommonMember 2019-01-01 2019-03-31 0001425289 us-gaap:CommonStockMember 2018-12-31 0001425289 us-gaap:SeriesAPreferredStockMember 2018-12-31 0001425289 us-gaap:SeriesBPreferredStockMember 2018-12-31 0001425289 us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember 2018-12-31 0001425289 us-gaap:RetainedEarningsMember 2018-12-31 0001425289 us-gaap:TreasuryStockCommonMember 2018-12-31 0001425289 us-gaap:CommonStockMember 2019-03-31 0001425289 us-gaap:SeriesAPreferredStockMember 2019-03-31 0001425289 us-gaap:SeriesBPreferredStockMember 2019-03-31 0001425289 us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember 2019-03-31 0001425289 us-gaap:RetainedEarningsMember 2019-03-31 0001425289 us-gaap:TreasuryStockCommonMember 2019-03-31 0001425289 2017-12-31 0001425289 2019-12-31 0001425289 2018-03-31 0001425289 2015-09-30 0001425289 2018-01-01 2018-12-31 0001425289 2017-02-28 0001425289 2018-02-05 0001425289 2015-12-09 0001425289 2016-03-24 0001425289 2016-07-27 0001425289 2018-07-03 0001425289 2018-05-09 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-Q

 

[X]  QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended:  March 31, 2019

 

or

 

[   ]  TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from _________to ________

 

Commission File Number:    000-54027

 

BRIGHTLANE CORP.

(Exact name of registrant as specified in its charter)

 

Nevada

 

30-0782905

(State or other jurisdiction of incorporation or organization)

 

(I.R.S. Employer Identification No.)

 

1600 West Loop South, Suite 600, Houston, Texas 77056

(Address of principal executive offices) (Zip Code)

 

(888) 468-2856

(Registrant’s telephone number, including area code)

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

Yes [X]   No [  ]

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate website, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).

Yes [X ]   No [  ]

 Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or emerging growth company. See definitions of “large accelerated filer,” “accelerated filer”, “smaller reporting company”, and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer

[   ]

Accelerated filer

[   ]

Non-accelerated filer

[   ]

Smaller reporting company

[X]

(Do not check if a smaller reporting company)

Emerging growth company 

[X]

 

 

Shares registered pursuant to Section 12(b) of the Act: None

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).

Yes [   ]   No [ X ]

 

As of May 15, 2019, the issuer had 39,692,654 shares of common stock outstanding.


1


TABLE OF CONTENTS

 

 

Page

PART I

 

Item 1. Financial Statements

3

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

14

Item 3 Quantitative and Qualitative Disclosures About Market Risk

16

Item 4 Controls and Procedures

16

 

 

PART II

 

Item 1. Legal Proceedings

17

Item IA. Risk Factors

17

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

17

Item 3. Defaults Upon Senior Securities

17

Item 4. Mine Safety Disclosures

17

Item 5. Other Information

17

Item 6. Exhibits

17

 

 

SIGNATURES

18

 


2


BRIGHTLANE CORP.

CONSOLIDATED BALANCE SHEETS

(Unaudited)

 

 

 

March 31,

2019

December

31, 2018

ASSETS

 

 

Current Assets

 

Cash and cash equivalents

$ 37,303  

$ 20,578  

Notes receivable - current portion

31,644  

31,644  

Total Current Assets

68,947  

52,222  

 

 

 

Notes receivable - long term portion

201,888  

204,498  

Investment in real estate, net

483,424  

488,429  

Total Assets

$ 754,259  

$ 745,149  

 

 

 

LIABILITIES AND STOCKHOLDERS' EQUITY

LIABILITIES

 

Current Liabilities

 

Accounts payable

$ 12,497  

$ 24,128  

Accrued expenses

58,715  

79,086  

Accrued interest

16,365  

37,527  

Line of credit

567,058  

373,850  

Current portion of convertible note payable

448,900  

-  

Current portion of convertible note payable – related party

428,786  

297,754  

Total Current Liabilities

1,532,321  

812,345  

 

 

 

Convertible note payable

69,503  

487,175  

Convertible note payable – related party

161,622  

285,237  

Total Liabilities

1,763,446  

1,584,757  

 

 

 

STOCKHOLDERS' EQUITY (DEFICIT)

Series A Preferred Voting Stock, $0.001 par value, 1 share authorized,

0 and 1 share issued and outstanding at March 31, 2019 and

 December 31, 2018 respectively

-  

-  

Series B Preferred Voting Stock, $0.001 par value, 1 share authorized,

 none and 1 share issued and outstanding at March 31, 2019 and

 December 31, 2018 respectively

-  

-  

Common stock, $0.001 par value, 250,000,000 shares authorized,

18,692,654 shares issued and outstanding at March 31, 2019 and December 31, 2018

18,693  

18,693  

Additional paid in capital

2,479,390  

2,479,390  

Treasury stock

-  

-  

Accumulated deficit

(3,507,270)  

(3,337,691)  

Total Stockholders’ Equity

(1,009,187)  

(839,608)  

Total Liabilities and Stockholders’ Equity

$ 754,259  

$ 745,149  

 

 

 

The accompanying notes are an integral part of these financial statements.


3


BRIGHTLANE CORP.

CONSOLIDATED STATEMENTS OF OPERATIONS

(Unaudited)

 

 

 

Three Months Ended March 31,

 

2019

2018

REVENUE

 

 

Fees

$ 1,714  

$ 8,445  

Interest

4,607  

-  

Rental income

15,503  

6,738  

Sale of real estate

-  

91,713  

Total Revenue

21,824  

106,896  

 

 

 

Cost of property sold

-  

(27,000)  

 

 

 

Gross Profit

21,824  

79,896  

 

 

 

OPERATING EXPENSES

Selling, general and administrative

165,508  

115,263  

 

 

 

NET OPERATING LOSS

(143,684)  

(35,367)  

 

 

 

OTHER EXPENSES

 

Interest expense - related party

8,462  

8,195  

Interest expense - other

17,443  

9,335  

 

 

 

LOSS BEFORE INCOME TAXES

$ (169,579)  

$ (52,897)  

Provision for income taxes

 

-  

Net loss

$ (169,579)  

$ (52,897)  

 

 

 

Basic and fully diluted loss per share

(0.01)  

(0.01)  

 

 

 

Weighted Average Number of Shares Outstanding:

Basic and Diluted

18,692,654  

17,342,654  

 

 

 

The accompanying notes are an integral part of these financial statements.


4


BRIGHTLANE CORP.

CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDERS’ DEFICIT

(Unaudited)

 

 

 

 

 

Common Stock

Series A

Preferred Voting

Stock

Series B

Preferred Voting

Stock

Additional

Paid-In

Accumulated

Treasury

Stockholders'

Equity

 

Shares

Amount

Shares

Amount

Shares

Amount

Capital

Deficit

Stock

(Deficit)

Balances at

January 1, 2018

19,422,667

$19,443

1  

$ -  

1  

$ -  

$4,223,571

$(2,931,837)

$(2,043,869)

$(732,691)

Net loss

-

-  

-  

-  

-  

-  

-

(52,897)

-

(52,897)

Balances at

March 31, 2018

19,422,667

$19,443

1  

$ -  

1  

$ -  

$4,223,571

$(2,984,734)

$(2,043,869)

$(785,588)

 

 

 

Common Stock

Series A

Preferred Voting

Stock

Series B

Preferred Voting

Stock

Additional

Paid-In

Accumulated

Treasury

Stockholders'

Equity

 

Shares

Amount

Shares

Amount

Shares

Amount

Capital

Deficit

Stock

(Deficit)

Balances at

January 1, 2019

18,692,654

$18,693

 

$ -  

 

$ -  

$2,479,390

$(3,337,691)

$    -

$(839,609)

Cancellation of

preferred stock

-

-

(1)  

-  

(1)  

-  

-

-

-

-

Net loss

-

-

 

-  

 

-  

-

(169,579)

-

(169,579)

Balances at

March 31, 2019

18,692,654

$18,693

-   

$ -  

 

$ -  

$2,479,390

$(3,507,270)

$    -

$(1,009,187)

 

 

 

 

 

 

The accompanying notes are an integral part of these financial statements.


5


BRIGHTLANE CORP.

CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited)

 

 

 

 

Three Months Ended March 31,

 

2019

2018

CASH FLOWS FROM OPERATING ACTIVITIES:

Net loss

$ (169,579)  

$ (52,897)  

Adjustments to reconcile net loss to net cash used in operating activities:

Depreciation

5,005  

2,810  

Accrued interest added to notes

38,645  

30,421  

Changes in Assets and Liabilities

Accounts receivable

-  

(926)  

Investment in real estate

-  

(482,250)  

Accounts payable

(11,631)  

(4,494)  

Accrued expenses

(20,371)  

6,250  

Accrued interest

(21,162)  

(15,255)    

NET CASH USED IN OPERATING ACTIVITIES

$ (179,093)  

$ (516,341)  

 

 

 

CASH FLOWS FROM INVESTING ACTIVITIES:

 

 

Principal payments of notes receivable

2,610  

-  

NET CASH PROVIDED BY INVESTING ACTIVITIES

2,610  

-  

 

 

 

CASH FLOWS FROM FINANCING ACTIVITIES:

Proceeds from advance of line of credit

193,208  

373,850  

Proceeds from convertible note payable

-  

63,750  

Payment on demand note payable

-  

(1,000)  

NET CASH PROVIDED BY FINANCING ACTIVITIES

$ 193,208  

$ 436,600  

 

 

 

Increase (decrease) in cash and cash equivalents

$ 16,725  

$ (79,741)  

Cash and cash equivalents at beginning of period

20,578  

134,650  

Cash and cash equivalents at end of period

$ 37,303  

$ 54,909  

 

 

The accompanying notes are an integral part of these financial statements.

 


6


BRIGHTLANE CORP.

NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

MARCH 31, 2019

 

 

NOTE 1 – ORGANIZATION AND BUSINESS

 

Brightlane Corp. (“we”, “our”, “us”, the “Company” or the “Registrant”) was initially incorporated under the laws of the State of Delaware in December 2006 under the name “Cold Gin Corporation.” On December 27, 2010, in connection with an Agreement and Plan of Reorganization we changed our domicile from Delaware to Nevada, our name to Bonanza Gold Corp.  In the third quarter of 2015, Brightlane Acquisition Corp. acquired a controlling interest in the Company from existing shareholders.  This change of control began the transitioning to a lease-to-own real estate company.  In connection with this transition, effective September 22, 2015 we changed our name to Brightlane Corp.

 

On December 21, 2015, we completed the agreement to acquire all of the outstanding shares of Brightlane Homes, Inc., which through its wholly owned subsidiary, acquired a 99.9% limited partner interest in Brightlane RECA, LP which was the beneficiary of the Brightlane RECA Trust which owned a portfolio of assets referred to as the Brightlane RECA Portfolio.  In April 2017, the partners of Brightlane RECA, LP amended the Revised Limited Partnership Agreement to admit Brightlane GP, Corp., an affiliate of the Registrant, as a General Partner of BL RECA LP.  This resulted in the transfer of all General Partner interests and powers to Brightlane GP Corp.  

 

On November 21, 2017, the Registrant entered into an Agreement resulting in the following actions:  (1) Brightlane #1, LLC, a subsidiary of Brightlane Homes, Inc., a wholly owned subsidiary of Brightlane Corp., transferred its limited partnership interest in Brightlane RECA LP, the sole beneficiary of the Brightlane RECA Trust, to GP 2002, LLC; and (2) Brightlane GP Corp, a wholly owned subsidiary of Brightlane Corp., transferred its general partnership interest in Brightlane RECA LP, the sole beneficiary of the Brightlane RECA Trust, to GP 2002, LLC.

 

The Agreement and the associated actions resulted in the termination of all agreements entered into on December 21, 2015 and all subsequent addenda to those agreements.  These actions terminate any rights of the Registrant to the Brightlane RECA Trust, thereby terminating all obligations to the underlying acquisition related debt associated with the assets contributed to the Brightlane RECA Trust.  In addition, per the November 21, 2017 Agreement the parties agreed that:  (1) the RECA Principals as defined in the Brightlane RECA Contribution Agreement agreed to return all of their common stock in the registrant totaling 2,100,013 common shares to the Registrant; and, (2) the RECA Principals agreed to facilitate the transfer of certain assets to Brightlane Homes, Inc., a wholly owned subsidiary of the Registrant.  

 

Brightlane Corp. now concentrates on being a real estate operator providing opportunities in the affordable housing market including reasonable rents and leases plus an opportunity to participate in a right-to-purchase program upon meeting certain criteria. Brightlane acquires single-family homes and portfolios of single-family homes and actively pursues the acquisition of these types of homes through one-off purchases, the purchase of portfolios, and other methods of acquisition.  We service a market that is historically underserved – those seeking living arrangements in the sub $150,000 home market. We continually seek out and make the appropriate investments in ancillary services.  

 

NOTE 2 – GOING CONCERN

 

The accompanying financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business.  The Company has only generated minimal revenues since inception, has sustained operating losses since inception, and has an accumulated deficit of $(3,507,270) and a working capital deficit of $1,463,374 at March 31, 2019.  These factors, among others, raise substantial doubt about the ability of the Company to continue as a going concern for a reasonable period of time.  The Company’s continuation as a going concern is dependent upon, among other things, its ability to generate revenues and its ability to obtain capital from third parties.  No assurance can be given that the Company will be successful in these efforts.  


7


 

Management plans to identify adequate sources of funding to provide operating capital for continued growth.  In addition, Management intends to continue accessing the $5 million credit facility obtained by its Brightlane – CLOC Acquisitions, LLC subsidiary in order to acquire additional homes that will provide a profitable revenue stream for the Company.

 

The financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts or the amounts and classification of liabilities that might be necessary should the Company be unable to continue as a going concern.

 

NOTE 3 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

Basis of Presentation

The Financial Statements and related disclosures have been prepared pursuant to the rules and regulations of the SEC.  The Financial Statements have been prepared under accounting principles generally accepted in the United States of America (“GAAP” accounting). The Company has adopted a December 31 fiscal year end.

 

Use of Estimates

The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date the financial statements and the reported amount of revenues and expenses during the reporting period. Actual results could differ from those estimates.

 

Principals of Consolidation

The consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles (GAAP). The consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries. All intercompany balances and transactions have been eliminated.

 

Cash and Cash Equivalents

The Company accounts for cash and cash equivalents under FASB ASC 305, “ Cash and Cash Equivalents ”, and considers all highly liquid investments with an original maturity of three months or less to be cash equivalents.  

 

Cash Flows Reporting

The Company follows ASC 230, “Statement of Cash Flows,” for cash flows reporting, classifies cash receipts and payments according to whether they stem from operating, investing, or financing activities and provides definitions of each category, and uses the indirect or reconciliation method (“Indirect method”) as defined by ASC 230 to report net cash flow from operating activities by adjusting net income to reconcile it to net cash flow from operating activities by removing the effects of (a) all deferrals of past operating cash receipts and payments and all accruals of expected future operating cash receipts and payments and (b) all items that are included in net income that do not affect operating cash receipts and payments. The Company reports the reporting currency equivalent of foreign currency cash flows, using the current exchange rate at the time of the cash flows and the effect of exchange rate changes on cash held in foreign currencies is reported as a separate item in the reconciliation of beginning and ending balances of cash and cash equivalents and separately provides information about investing and financing activities not resulting in cash receipts or payments in the period.

 

Convertible Instruments

The Company evaluates and account for conversion options embedded in convertible instruments in accordance with ASC 815 “Derivatives and Hedging Activities”.

 

Applicable GAAP requires companies to bifurcate conversion options from their host instruments and account for them as free standing derivative financial instruments according to certain criteria. The criteria include circumstances in which (a) the economic characteristics and risks of the embedded derivative instrument are not clearly and closely related to the economic characteristics and risks of the host contract, (b) the hybrid instrument that embodies both the embedded derivative instrument and the host contract is not re-measured at fair value under other GAAP with changes in fair value reported in earnings as they occur and (c) a separate instrument with the same terms as the embedded derivative instrument would be considered a derivative instrument.

 

The Company accounts for convertible instruments (when it has been determined that the embedded conversion options should not be bifurcated from their host instruments) as follows: The Company records when necessary, discounts to convertible notes for the intrinsic value of conversion options embedded in debt


8


instruments based upon the differences between the fair value of the underlying common stock at the commitment date of the note transaction and the effective conversion price embedded in the note. Debt discounts under these arrangements are amortized over the term of the related debt to their stated date of redemption.

 

Revenue Recognition

Effective January 1, 2018, the Company adopted guidance issued by the FASB regarding recognizing revenue from contracts with customers.  The revenue recognition policies as enumerated below reflect the Company's accounting policies effective January 1, 2018, which did not have a materially different financial statement result than what the results would have been under the previous accounting policies for revenue recognition.

Brightlane Corp.’s revenue results from four sources related to the acquisition/disposal and renting/leasing of real estate properties:  

 

(1) Fees related to the management of properties.  We collect a monthly management fee for each home that we manage on a third party basis for our portfolio clients.  In many instances we also collect late fees. 

(2) Interest income on notes receivable.  We carry principle balances on notes receivable and in return for carrying these notes we receive monthly principal and interest payments on these notes receivable.  We apportion the payments as received to reducing the principle balance and book the balance to fees due us as well as interest income.   

(3) Rental income on properties we own.  We own properties and rent or lease them to our tenants and book this as rental income. 

(4) Sale of real estate.  Periodically, as market conditions allow, we dispose of a property.  Once sold, book the net proceeds after customary closing costs as sale of real estate.   

 

The following table disaggregates revenue by major source for the three months ended March 31, 2019:

 

Year Ended March 31, 2019

 

Total

Fees Income

 

$

1,714

Interest Income

 

 

4,607

Rental Income

 

 

15,503

Total Revenue

 

$

21,824

 

Deferred Income Taxes and Valuation Allowance

The Company accounts for income taxes under ASC 740 Income Taxes .  Under the asset and liability method of ASC 740, deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statements carrying amounts of existing assets and liabilities and their respective tax bases.  Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled.  The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period the enactment occurs.  A valuation allowance is provided for certain deferred tax assets if it is more likely than not that the Company will not realize tax assets through future operations.  No deferred tax assets or liabilities were recognized at March 31, 2019 and December 31, 2018.  The Company has provided a full valuation allowance for its deferred tax asset resulting from net operating losses.

 

Earnings (Loss) Per Share

The Company computes basic and diluted earnings per share amounts in accordance with ASC Topic 260, “ Earnings per Share .” Basic earnings per share is computed by dividing net income (loss) available to common shareholders by the weighted average number of common shares outstanding during the reporting period. Diluted earnings per share reflects the potential dilution that could occur if stock options and other commitments to issue common stock were exercised or equity awards vest resulting in the issuance of common stock that could share in the earnings of the Company.  

 

Financial Instruments

The Company’s balance sheet includes certain financial instruments: primarily accounts payable, accruals and debt obligations. The carrying amounts of current assets and current liabilities approximate their fair value because of the relatively short period of time between the origination of these instruments and their expected realization.

 

ASC 820, “ Fair Value Measurements and Disclosures ,” defines fair value as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. ASC


9


820 also establishes a fair value hierarchy that distinguishes between (1) market participant assumptions developed based on market data obtained from independent sources (observable inputs) and (2) an entity’s own assumptions about market participant assumptions developed based on the best information available in the circumstances (unobservable inputs). The fair value hierarchy consists of three broad levels, which gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1) and the lowest priority to unobservable inputs (Level 3). The three levels of the fair value hierarchy are described below:

 

Level 1 - Unadjusted quoted prices in active markets that are accessible at the measurement date for identical, unrestricted assets or liabilities. 

Level 2 - Inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly, including quoted prices for similar assets or liabilities in active markets; quoted prices for identical or similar assets or liabilities in markets that are not active; inputs other than quoted prices that are observable for the asset or liability (e.g., interest rates); and inputs that are derived principally from or corroborated by observable market data by correlation or other means. 

Level 3 - Inputs that are both significant to the fair value measurement and unobservable. 

 

Fair value estimates discussed herein are based upon certain market assumptions and pertinent information available to management as of March 31, 2019. The respective carrying value of certain on-balance-sheet financial instruments approximated their fair values due to the short-term nature of these instruments.

 

The Company does not have any assets or liabilities measured at fair value on a recurring basis.

 

Investments in non-consolidated subsidiaries

Investments in non-consolidated entities are accounted for using the equity method or cost basis depending upon the level of ownership and/or the Company's ability to exercise significant influence over the operating and financial policies of the investee. When the equity method is used, investments are recorded at original cost and adjusted periodically to recognize the Company's proportionate share of the investees' net income or losses after the date of investment. When net losses from an investment accounted for under the equity method exceed its carrying amount, the investment balance is reduced to zero and additional losses are not provided for. The Company resumes accounting for the investment under the equity method if the entity subsequently reports net income and the Company's share of that net income exceeds the share of net losses not recognized during the period the equity method was suspended. Investments are written down only when there is clear evidence that a decline in value that is other than temporary has occurred.

 

Long-lived Assets

Long-lived assets such as property, equipment and identifiable intangibles are reviewed for impairment whenever facts and circumstances indicate that the carrying value may not be recoverable. When required impairment losses on assets to be held and used are recognized based on the fair value of the asset. The fair value is determined based on estimates of future cash flows, market value of similar assets, if available, or independent appraisals, if required. If the carrying amount of the long-lived asset is not recoverable from its undiscounted cash flows, an impairment loss is recognized for the difference between the carrying amount and fair value of the asset. When fair values are not available, the Company estimates fair value using the expected future cash flows discounted at a rate commensurate with the risk associated with the recovery of the assets. We did not recognize any impairment losses for any periods presented.

 

Property and Equipment

The Company follows ASC 360, Property, Plant, and Equipment, for its fixed assets.  Equipment is stated at cost less accumulated depreciation. Depreciation is calculated on a straight-line basis over the estimated useful lives of the assets (3 years).

 

Related Parties

The Company follows ASC 850, “Related Party Disclosures,” for the identification of related parties and disclosure of related party transactions.  

 

Restricted Stock

The Company issues restricted stock to consultants for various services. Cost for these transactions are measured at the fair value of the consideration received or the fair value of the equity instruments issued, whichever is measurable more reliably measurable. The value of the common stock is measured at the earlier


10


of (i) the date at which a firm commitment for performance by the counterparty to earn the equity instruments is reached or (ii) the date at which the counterparty's performance is complete.

 

Stock-Based Compensation

FASB ASC 718 “Compensation – Stock Compensation,” prescribes accounting and reporting standards for all stock-based payments award to employees, including employee stock options, restricted stock, employee stock purchase plans and stock appreciation rights, may be classified as either equity or liabilities. The Company determines if a present obligation to settle the share-based payment transaction in cash or other assets exists. A present obligation to settle in cash or other assets exists if: (a) the option to settle by issuing equity instruments lacks commercial substance or (b) the present obligation is implied because of an entity’s past practices or stated policies. If a present obligation exists, the transaction should be recognized as a liability; otherwise, the transaction should be recognized as equity.

 

The Company accounts for stock-based compensation issued to non-employees and consultants in accordance with the provisions of FASB ASC 505-50 “ Equity – Based Payments to Non-Employees .” Measurement of share-based payment transactions with non-employees is based on the fair value of whichever is more reliably measurable: (a) the goods or services received; or (b) the equity instruments issued. The fair value of the share-based payment transaction is determined at the earlier of performance commitment date or performance completion date.

 

Recently Issued Accounting Pronouncements

We have reviewed the FASB issued Accounting Standards Update (“ASU”) accounting pronouncements and interpretations thereof that have effectiveness dates during the periods reported and in future periods. The Company has carefully considered the new pronouncements that alter previous generally accepted accounting principles and does not believe that any new or modified principles will have a material impact on the corporation’s reported financial position or operations in the near term. The applicability of any standard is subject to the formal review of our financial management and certain standards are under consideration.

 

NOTE 4 – LINE OF CREDIT FACILITIES

 

On May 19, 2017, Brightlane – CLOC Acquisitions, L.L.C., a Delaware limited liability company and a wholly owned subsidiary of the registrant entered into a $5,000,000 revolving credit facility with CoreVest Finance (f/k/a Colony American Finance Lender, LLC).  This credit facility is for the acquisition of residential homes providing the Company an acquisition vehicle.  General provisions of this credit facility are an 18 month term at 9%, with a loan to value of 80%.  At March 31, 2019 the Company had utilized this credit facility to complete two transactions resulting in the acquisition of real estate assets totaling $488,750 of which $373,850 was financed utilizing the credit facility.  The balance of the line of credit was $373,850 at March 31, 2019.

 

On February 15, 2019, we entered into a loan agreement with a UK-based lender to provide funding to the Company on an as required basis.  The Company provides funding requests to the lender for general and administrative expenses, which once approved, provide adequate working capital for the Company to fund operations.  The general provision for this credit facility is a one year term at 10% interest per annum which is paid following the close of each quarter.  At March 31, 2019 the Company received advances on this credit facility in the amount of $193,208, and has incurred interest expenses of $1,118.

 

NOTE 5 – NOTES RECEIVABLE

 

As part of the agreement entered into on November 21, 2017, the Company assumed nine notes receivable totaling $243,264.  These notes are secured by residential properties.  The terms associated with these notes range from 11 years to 30 years, with interest rates ranging from 9.3% to 10%.  During the three months ended March 31, 2019, principal payments towards notes receivables totaled $2,610, reducing notes receivable to $233,532.  The current portion of these notes is $31,644.

 

NOTE 6 – NOTES PAYABLE

 

On September 30, 2015 the Company borrowed $60,723 from a third party.  The note bears interest at 8% per annum and is payable on demand. Interest is paid quarterly. The note was convertible into common stock of the Company at $0.50 per share.  On January 28, 2016, the Company made a principal payment of $10,723, bringing the outstanding principal to $50,000 on this note.  The lender elected to have interest accrue for the 3 months ended December 31, 2017 thereby increasing the principal due to $51,000 at December 31,2017.  The Company made a principal and interest payment during the year ended December 31, 2018 totaling $2,020 reducing the principal balance to $50,000 and subsequently on May 9, 2018 the lender elected to exercise his option to convert


11


the remaining $50,000 principal balance into 100,000 shares of common stock reducing the principal balance to $0.  Interest expense incurred during the three months ended March 31, 2019 and the year ended December 31, 2018 was $0 and $1,447 respectively.

 

On February 28, 2017 the Company borrowed $400,000 from a third party.  The promissory note carries an interest rate of 6% per annum with a maturity date of February 28, 2020.  The lender may convert into shares of our common stock after one year, at $0.20 per share.  The lender has the option of accruing interest or receiving interest only payment annually.  On the anniversary of this note, the lender elected to have interest accrued thereby increasing the principal due to $423,424 at December 31, 2018.  On September 20, 2018 the Company and the lender agreed to amend certain terms of the note due to market conditions extending the maturity date by one year and setting the conversion rate to the current $0.20 per share.  Interest expense incurred during the three months ended March 31, 2019 and the year ended December 31, 2018 was $6,394 and $25,248 respectively.

 

On February 5, 2018 the Company issued a note to a third party for the remaining balance owed on properties acquired in a real estate transaction for $63,750.  The promissory note carries an interest rate of 9% per annum with a maturity date of February 5, 2021.  The lender may convert into shares of our common stock after one year, at $0.20 per share.  The lender has the option of accruing interest or receiving interest only payment annually.  On September 20, 2018 the Company and the lender agreed to amend certain terms of the note due to market conditions extending the maturity date by one year and setting the conversion rate to the current $0.20 per share.  Interest expense incurred during the three months ended March 31, 2019 and the year ended December 31, 2018 was $1,508 and $5,187 respectively.

 

NOTE 7 – RELATED PARTY TRANSACTIONS

 

On December 9, 2015, we entered into a subscription agreement to sell one unit consisting of a $250,000 promissory note, one share of Series A Preferred Voting Stock and one share of Series B Preferred Voting Stock to a related-party in exchange for $250,000 and the investor’s agreement to utilize its best efforts to cause a capital injection of up to $3,000,000.00 into the Company on or before January 1, 2017 (extended to January 1, 2019).  The promissory note carries an interest rate of 6% per annum with a maturity date of December 9, 2019.  The lender may convert into shares of our common stock after one year, at $0.20 per share.  The lender has the option of accruing interest or receiving interest only payment annually. On the anniversary of this note, the lender elected to have interest accrued thereby increasing the principal due to $297,754 at December 31, 2018. On September 20, 2018 the Company and the lender agreed to amend certain terms of the note due to market conditions extending the maturity date by one year and setting the conversion rate to the current $0.20 per share.  Interest expense incurred during the three months ended March 31, 2019 and the year ended December 31, 2018 was $4,405 and $16,915 respectively.

 

On March 24, 2016, we received an additional $110,000 in capital from the aforementioned related party as an advance on the commitments this related party has to us.  The promissory note carries an interest rate of 6% per annum with a maturity date of March 24, 2020.  The lender may convert into shares of our common stock after one year, at $0.20 per share.  The lender has the option of accruing interest or receiving interest only payment annually.  On the anniversary of this note, the lender elected to have interest accrued thereby increasing the principal due to $123,615 at December 31, 2018.  On September 20, 2018 the Company and the lender agreed to amend certain terms of the note due to market conditions extending the maturity date by one year and setting the conversion rate to the current $0.20 per share.  Interest expense incurred during the three months ended March 31, 2019 and the year ended December 31, 2018 was $1,839 and $7,323 respectively.

 

On July 27, 2016, we received an additional $499,200 in capital from the aforementioned related party as an advance on the commitments this related party has to us.  The promissory note carries an interest rate of 6% per annum with a maturity date of July 27, 2020  The lender may convert into shares of our common stock after one year, at $0.50 per share.  The lender has the option of accruing interest or receiving interest only payment annually.  During the year ended December 31, 2016, we repaid a total of $360,000 to the related party toward this promissory note.  On the anniversary of this note, the lender elected to have interest accrued thereby increasing the principal due to $161,621 at December 31, 2018.  On September 20, 2018 the Company and the lender agreed to amend certain terms of the note due to market conditions extending the maturity date by one year and setting the conversion rate to the current $0.20 per share.  Interest expense incurred during the three months ended March 31, 2019 and the year ended December 31, 2018 was $2,391 and $9,431 respectively.

 

Mr. Steve Helm sits on the board of directors and also serves as the Company’s Chief Executive Officer.  As compensation for his services we are accruing annual compensation of $25,000 as of January 1, 2016.  We will continue to accrue his compensation at a quarterly rate of $6,250 going forward.  On July 3, 2018, the Company


12


issued 1,250,000 shares of its common stock to Mr. Helm in return for a total investment into the Company of $248,938.  The total investment into the Company consisted of a contribution of funds as well as the assumption of certain liabilities and accrued expenses.  The accrued expenses were a result of the accrual of the annual compensation at a rate of $6,250 per quarter from January 1, 2016 through May 15, 2018.  From May 15, 2018 through March 31, 2019 we continued to accrue an annual compensation for Mr. Helm at a rate of $6,250 per quarter.  Accrued compensation for the three months ended March 31, 2019 and the year ended December 31, 2018 was $6,250 and $15,625 respectively.

 

NOTE 8– SHAREHOLDERS’ EQUITY

 

Common Stock

 

The Company has 250,000,000 authorized common shares with a par value of $0.001 per share.  Each common share entitles the holder to one vote, in person or proxy, on any matter on which action of the stockholders of the corporation is sought.

 

The Company issued 100,000 shares of its common stock on May 9, 2018, for the conversion of a $50,000 principal balance of a convertible note payable.

On July 3, 2018, the Company issued 1,250,000 shares of its common stock to its Chief Executive Officer in return for a total investment into the Company of $248,938.  The total investment into the Company consisted of a contribution of funds as well as the assumption of certain liabilities and accrued expenses.

 

No issuance of the Company’s common stock occurred during the three months ended March 31, 2019.

 

There were 18,692,654 common shares issued and outstanding at March 31, 2019.

 

Preferred Stock

 

On March 12, 2019, the Company terminated the subscription agreement entered into with Brightlane Acquisition Corp. (the “Investor”). on December 9, 2015.  The Investor is an affiliate shareholder of the Company.  Pursuant to this agreement, the Company sold a $250,000 promissory note, one share of Series A Preferred Voting Stock, and one share of Series B Preferred Voting Stock to the Investor in exchange for $250,000 and for the Investor’s agreement to utilize its best efforts to cause a capital injection of up to $3,000,000 into the Company on or before January 1, 2017.  This agreement has been renewed up through March 12, 2019.  The agreement was terminated due to the Board determining that it was no longer desirable to continue extending the agreement.  As a result of this termination, the Series A and Series B Preferred Voting Stock has been returned to the Company for cancellation.  There are no penalties incurred by terminating this agreement.

 

At March 31, 2019, there is no preferred stock outstanding.  

 

Warrants issued in connection with sale of common shares

 

At March 31, 2019 there are no warrants outstanding.

 

NOTE 9 – SUBSEQUENT EVENTS

 

On April 3, 2019, the board of directors of Brightlane Corp., approved a share exchange agreement with VAT Bridge Ltd., a United Kingdom based entity.  Pursuant to this agreement, Brightlane will issue 21,000,000 common shares to the owners of VAT Bridge in return for all outstanding shares of VAT Bridge.  These shares shall be issued to VAT Bridge shareholders proportionately to their current ownership interest in VAT Bridge.  As a result of this agreement, VAT Bridge will become a wholly owned subsidiary of Brightlane.


13


Item 2.  Management’s Discussion and Analysis of Financial Condition and Results of Operations.

 

The following analysis of our financial condition and results of operations for the period January 1, 2019 through March 31, 2019 should be read in conjunction with the financial statements, including footnotes, and other information presented elsewhere in this Report on Form 10-Q and the risk factors and the financial statements for the year ended December 31, 2018 and the other information set forth in our Annual Report on Form 10-K for the year ended December 31, 2018 filed with the Securities and Exchange Commission on April 16, 2019.  In addition to historical information, the following discussion contains forward-looking statements that involve risks, uncertainties and assumptions. Where possible, we have tried to identify these forward looking statements by using words such as “anticipate,” “believe,” “intends,” or similar expressions. Our actual results could differ materially from those anticipated by the forward-looking statements due to important factors and risks including, but not limited to, those set forth under “Risk Factors” in Part I, Item 1A of our Annual Report on Form 10-K filed with the Securities and Exchange Commission on April 16, 2019.

 

Working Capital

 

 

 

March 31, 2019

 

 

December 31, 2018

 

Current Assets

 

$

68,947

 

 

$

52,222

 

Current Liabilities

 

$

1,532,321

 

 

$

812,345

 

Working Capital

 

$

(1,463,374

)

 

$

(760,123

)

 

Cash Flows

  

 

Three Months Ended March 31,

 

 

 

2019

 

 

2018

 

Cash Flows Provided by (Used In) Operating Activities

 

$

(179,093

 

$

(516,341

)

Cash Flows used in Investing Activities

 

$

2,610

 

 

$

-

 

Cash Flows Provided by Financing Activities

 

$

193,208

 

 

$

436,600

 

Net change in Cash During Period

 

$

16,725

 

 

$

(79,741

)

 

Results of Operations for the three months ended March 31, 2019 and 2018

 

For the three months ended March 31, 2019 and 2018, total revenues were $21,824 and $106,896, respectively; and net losses were $169,579 and $52,897 respectively.

 

Total revenue for the three months ended March 31, 2019 were primarily attributable to rental and management fee income recognized from the operations of our Brightlife Management as well as interest income on notes receivables.  For the three months ended March 31, 2019, our Brightlife Management subsidiary generated $15,503 in proceeds from rental income, as well as collecting interest on land contracts of $4,607 and addition $1,714 primarily attributes to property management fees.  During the three months ended March 31, 2019 and 2018, we had selling, general and administrative expenses of $165,508 and $115,263 respectively.  During the three months ended March 31, 2019 and 2018 we incurred interest expenses of $25,905 and $17,530 respectively.

 

The net losses were attributable to operating expenses and other expenses that primarily consisted of expenses related to the implementation of the Company’s business model of a lease-to-own real estate business in addition to payroll, accrual in management fees, employee benefits, the acquisition and management of real estate, rent expenses for our facilities, and accrued interest on our notes payable.  The operating expenses for the three months ended March 31, 2019 and 2018 were primarily general and administrative in nature and included legal fees, management and consulting fees, and audit and accounting fees.

 

Liquidity and Capital Resources

 

Liquidity

At March 31, 2019, we had cash and cash equivalents of $37,303. We have incurred negative cash flows from operations since we started our business.  We have spent and expect to continue to spend, substantial amounts in connection with implementing our business strategy, including our planned real estate acquisitions.

 

For the three months ended March 31, 2019, we recorded a net loss of $169,579.  We had a negative change of $11,631 due to the accounts payable, a negative change of $20,371 from accrued expenses, a negative change of $21,162 due to accrue interest, a positive change in accrued interest added to note balances of $38,645 and a


14


positive change of $5,005 due to accumulated depreciation.  As a resulted, we had net cash used in operating activities of $179,093 for the three months ended March 31, 2019.

 

For the three months ended March 31, 2018, we recorded a net loss of $52,897.  We had a negative change of $926 due to accounts receivable, a negative change of $4,494 due to the accounts payable, a positive change of $6,250 from accrued expenses, a negative change of $15,255 due to accrue interest, a positive change in accrued interest added to note balances of $30,421, a negative change of $482,250 due to investments in real estate and a positive change of $2,810 due to accumulated depreciation.  As a resulted, we had net cash used in operating activities of $516,341 for the three months ended March 31, 2018.

 

During the three months ended March 31, 2019, we received proceeds in the amount of $2,610 for the collection on notes receivables.  We did not pursue any investing activities during the three months ended March 31, 2018.

 

For the three months ended March 31, 2019, we received proceeds from advances on a line of credit in the amount of $193,208 for general and administrative expenses and funding operations.  As a result, we had net cash provided by financing activities of $193,208 for the three months ended March 31, 2019.    

 

For the three months ended March 31, 2018, we drew on our line of credit in the amount of $373,850 for the acquisition of multiple real estate assets, and we issued a note in the amount of $63,750 to one of the parties from whom we acquire certain real estate assets for the balance remaining on the homes acquired.  We also paid back $1,000 in principal on a demand note to a third party.  As a result, we had net cash provided by financing activities of $436,600 for the three months ended March 31, 2018.

 

The actual amount of funds we will need to operate is subject to many factors, some of which are beyond our control. We have based our estimate on assumptions that may prove to be wrong. We may need to obtain additional funds sooner or in greater amounts than we currently anticipate. Potential sources of financing include strategic relationships, public or private sales of our shares or debt and other sources. We may seek to access the public or private equity markets when conditions are favorable due to our long-term capital requirements.  While we have a best efforts commitment from the aforementioned accredited investor it is uncertain when such additional funding will be available and whether the terms will be acceptable to us. If we raise funds by selling additional shares of common stock or other securities convertible into common stock, the ownership interest of our existing stockholders will be diluted. If we are not able to obtain financing when needed, we may be unable to carry out our business plan. As a result, we may have to significantly limit our operations and our business, financial condition and results of operations would be materially harmed.

 

We have no known demands or commitments and are not aware of any events or uncertainties as of March 31, 2019, other than the work commitment previously mentioned, that will result in or that are reasonably likely to materially increase or decrease our current liquidity.

 

Capital Resources

We had no material commitments for capital expenditures as of March 31, 2019.

 

Off Balance Sheet Arrangements

There are no off balance sheet arrangements.


15


Item 3. Quantitative and Qualitative Disclosures about Market Risk.

 

Not applicable because the Company is a smaller reporting company.

 

Item 4. Controls and Procedures.

 

Evaluation of Disclosure Controls and Procedures

 

Disclosure controls and procedures are controls and procedures that are designed to ensure that information required to be disclosed in our reports filed under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the SEC's rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by our company in the reports that it files or submits under the Exchange Act is accumulated and communicated to our management, including our Principal Executive Officer who is also our Principal Financial Officer, or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure. Our management carried out an evaluation under the supervision and with the participation of our Principal Executive Officer who is also our Principal Financial Officer, of the effectiveness of the design and operation of our disclosure controls and procedures pursuant to Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934 ("Exchange Act"). Based upon that evaluation, our Principal Executive Officer who is also our Principal Financial Officer have concluded that our disclosure controls and procedures were not effective as of March 31, 2019, due to the material weaknesses resulting from the Board of Directors not currently having any independent members and no director qualifies as an audit committee financial expert as defined in Item 407(d)(5)(ii) of Regulation S-K, and controls were not designed and in place to ensure that all disclosures required were originally addressed in our financial statements.

 

Changes in Internal Control over Financial Reporting

 

Our management has also evaluated our internal control over financial reporting, and there have been no significant changes in our internal controls or in other factors that could significantly affect those controls subsequent to the date of our last evaluation.

 

The Company is not required by current SEC rules to include, and does not include, an auditor's attestation report. The Company's registered public accounting firm has not attested to Management's reports on the Company's internal control over financial reporting.


16


PART II - OTHER INFORMATION

 

Item 1. Legal Proceedings.

 

We are not currently a party to any legal proceedings, and we are not aware of any proceeding pending or threatened against us by any governmental authority or other party.

 

Item 1A.  Risk Factors.

 

Not applicable because the Company is a smaller reporting company.

 

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.

 

1. Quarterly Issuances:

 

We did not issue any unregistered securities during the quarter.

 

2. Subsequent Issuances:

 

Subsequent to the quarter, we did not issue any unregistered securities other than as previously disclosed.

 

Item 3. Defaults upon Senior Securities.

 

None.

 

Item 4. Mine Safety Disclosures

 

Not Applicable.

 

Item 5. Other Information.

 

None.

 

Item 6. Exhibits.

 

31.1 Certification pursuant to Rule 13a-14(a)/15d-14(a) (1)  

    

32.1 Certification pursuant to Section 1350 of the Sarbanes-Oxley Act of 2002 (1)  

 

101.SCH XBRL Taxonomy Extension Schema Document 

101.CAL XBRL Taxonomy Extension Calculation Linkbase Document 

101.DEF XBRL Taxonomy Extension Definition Linkbase Document 

101.LAB XBRL Taxonomy Extension Label Linkbase Document 

101.PRE XBR Taxonomy Extension Presentation Linkbase Document 


17


SIGNATURES

 

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned .

 

 

 

BRIGHTLANE CORP.

 

Date:  May 15, 2019 By: /s/ Steve Helm    

Steve Helm

President and Chief Executive Officer

(Principal Executive Officer, Principal Accounting Officer

and Principal Financial Officer)

 

/s/Steve Helm

Director

 

/s/David Hill II

Director

 

/s/James Odell Barnes, Jr.

Director


18